At Access InVivo, we’re passionate about improving global health by ensuring patients have access to life-changing innovations. Our mission is to help companies bring medicines to patients faster knowing that access is fully aligned with commercial success. Our work is supported by insights from the most distinguished set of access leaders ever assembled by a consultancy, each recognised as a thought-leader in their fields. Our advice is unique in that it is driven by extensive real-world experience in access decision-making, medicines development and commercialisation.
We work with clients, who range from Top 5 Pharma companies to SMEs, to develop and execute innovative regulatory strategies from early product development to post-licensing activities for medicines and medical devices.
We pride ourselves on our understanding of clients’ needs and our flexible, creative and pragmatic approach puts our clients and the patients they serve at the centre of everything we do.
GreyRigge Associates is a global biotech partner delivering consultancy, management expertise and training across the entire product development journey. Our extensive biopharmaceutical industry experience and pragmatic, agile approach enables transformational success by accelerating our clients’ medicines to market.
IDEA is passionate about getting innovative products to patients with unmet needs and we particularly enjoy putting our full weight of innovative thinking and regulatory expertise behind innovative medicine.
Scendea is an international product development, regulatory and compliance consulting group serving the pharmaceutical and biotechnology industry.
Scendea’s expert team delivers strategic and operational support in the fields of Non-Clinical, CMC, Clinical and Regulatory to successfully guide products from early development to marketing approval.
In addition, our dedicated Compliance division strengthens development programs through CRO & CDMO oversight, GxP audits, Quality Management System (QMS) support, and GxP training, ensuring robust quality frameworks and inspection readiness throughout the product lifecycle.
A combination of scientific excellence, industry experience, commercial awareness and a collaborative approach allows our team to solve complex issues associated with medicinal product development. With team members based in the US, the Netherlands, Australia and the UK, Scendea delivers innovative, high-quality solutions aligned with jurisdiction-specific regulatory requirements.
At Scendea we collaborate, innovate, and together with our clients, we succeed.